참고문헌
- Takahashi K and Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 https://doi.org/10.1016/j.cell.2006.07.024
- Rando TA and Chang HY (2012) Aging, rejuvenation, and epigenetic reprogramming: resetting the aging clock. Cell 148, 46-57 https://doi.org/10.1016/j.cell.2012.01.003
- Yu J, Vodyanik MA, Smuga-Otto K et al (2007) Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917-1920 https://doi.org/10.1126/science.1151526
- Blasco MA, Serrano M and Fernandez-Capetillo O (2011) Genomic instability in iPS: time for a break. EMBO J 30, 991-993 https://doi.org/10.1038/emboj.2011.50
- Suva ML, Riggi N and Bernstein BE (2013) Epigenetic reprogramming in cancer. Science 339, 1567-1570 https://doi.org/10.1126/science.1230184
- Ruiz S, Panopoulos AD, Herrerias A et al (2011) A high proliferation rate is required for cell reprogramming and maintenance of human embryonic stem cell identity. Curr Biol 21, 45-52 https://doi.org/10.1016/j.cub.2010.11.049
- Lopez-Otin C, Blasco MA, Partridge L, Serrano M and Kroemer G (2013) The hallmarks of aging. Cell 153, 1194-1217 https://doi.org/10.1016/j.cell.2013.05.039
- Marion RM, Strati K, Li H et al (2009) Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 4, 141-154 https://doi.org/10.1016/j.stem.2008.12.010
- Weissbein U, Benvenisty N and Ben-David U (2014) Quality control: Genome maintenance in pluripotent stem cells. J Cell Biol 204, 153-163 https://doi.org/10.1083/jcb.201310135
- Folmes CD, Nelson TJ, Martinez-Fernandez A et al (2011) Somatic oxidative bioenergetics transitions into pluripotencydependent glycolysis to facilitate nuclear reprogramming. Cell Metab 14, 264-271 https://doi.org/10.1016/j.cmet.2011.06.011
- Banito A, Rashid ST, Acosta JC et al (2009) Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev 23, 2134-2139 https://doi.org/10.1101/gad.1811609
- Kimura H, Hayashi-Takanaka Y, Stasevich TJ and Sato Y (2015) Visualizing posttranslational and epigenetic modifications of endogenous proteins in vivo. Histochem Cell Biol 144, 101-109 https://doi.org/10.1007/s00418-015-1344-0
- Xiao Y and Chen J (2013) Proteomics approaches in the identification of molecular signatures of mesenchymal stem cells. Adv Biochem Eng Biotechnol 129, 153-176
- Mu WL, Wang YJ, Xu P et al (2015) Sox2 Deacetylation by Sirt1 Is Involved in Mouse Somatic Reprogramming. Stem Cells 33, 2135-2147 https://doi.org/10.1002/stem.2012
- Mostoslavsky R, Chua KF, Lombard DB et al (2006) Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell 124, 315-329 https://doi.org/10.1016/j.cell.2005.11.044
- Laurent LC, Ulitsky I, Slavin I et al (2011) Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 8, 106-118 https://doi.org/10.1016/j.stem.2010.12.003
- Taapken SM, Nisler BS, Newton MA et al (2011) Karotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells. Nat Biotechnol 29, 313-314 https://doi.org/10.1038/nbt.1835
- Araten DJ, Golde DW, Zhang RH et al (2005) A quantitative measurement of the human somatic mutation rate. Cancer Res 65, 8111-8117 https://doi.org/10.1158/0008-5472.CAN-04-1198
- Morin GB (1989) The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59, 521-529 https://doi.org/10.1016/0092-8674(89)90035-4
- Vaziri H, Chapman KB, Guigova A et al (2010) Spontaneous reversal of the developmental aging of normal human cells following transcriptional reprogramming. Regen Med 5, 345-363 https://doi.org/10.2217/rme.10.21
- Marion RM and Blasco MA (2010) Telomere rejuvenation during nuclear reprogramming. Curr Opin Genet Dev 20, 190-196 https://doi.org/10.1016/j.gde.2010.01.005
- Yehezkel S, Rebibo-Sabbah A, Segev Y et al (2011) Reprogramming of telomeric regions during the generation of human induced pluripotent stem cells and subsequent differentiation into fibroblast-like derivatives. Epigenetics 6, 63-75 https://doi.org/10.4161/epi.6.1.13390
- Pasi CE, Dereli-Oz A, Negrini S et al (2011) Genomic instability in induced stem cells. Cell Death Differ 18, 745-753 https://doi.org/10.1038/cdd.2011.9
- Lopez-Contreras AJ, Gutierrez-Martinez P, Specks J, Rodrigo-Perez S and Fernandez-Capetillo O (2012) An extra allele of Chk1 limits oncogene-induced replicative stress and promotes transformation. J Exp Med 209, 455-461 https://doi.org/10.1084/jem.20112147
- Ruiz S, Lopez-Contreras AJ, Gabut M et al (2015) Limiting replication stress during somatic cell reprogramming reduces genomic instability in induced pluripotent stem cells. Nat Commun 6, 8036 https://doi.org/10.1038/ncomms9036
- Mishra P and Chan DC (2014) Mitochondrial dynamics and inheritance during cell division, development and disease. Nat Rev Mol Cell Biol 15, 634-646 https://doi.org/10.1038/nrm3877
- Ji J, Sharma V, Qi S et al (2014) Antioxidant supplementation reduces genomic aberrations in human induced pluripotent stem cells. Stem Cell Reports 2, 44-51 https://doi.org/10.1016/j.stemcr.2013.11.004
- Facucho-Oliveira JM, Alderson J, Spikings EC, Egginton S and St John JC (2007) Mitochondrial DNA replication during differentiation of murine embryonic stem cells. J Cell Sci 120, 4025-4034 https://doi.org/10.1242/jcs.016972
- Moussaieff A, Rouleau M, Kitsberg D et al (2015) Glycolysis-mediated changes in acetyl-CoA and histone acetylation control the early differentiation of embryonic stem cells. Cell Metab 21, 392-402 https://doi.org/10.1016/j.cmet.2015.02.002
- Prigione A, Fauler B, Lurz R, Lehrach H and Adjaye J (2010) The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells. Stem Cells 28, 721-733 https://doi.org/10.1002/stem.404
- Mandal S, Lindgren AG, Srivastava AS, Clark AT and Banerjee U (2011) Mitochondrial function controls proliferation and early differentiation potential of embryonic stem cells. Stem Cells 29, 486-495 https://doi.org/10.1002/stem.590
- Sathananthan H, Pera M and Trounson A (2002) The fine structure of human embryonic stem cells. Reprod Biomed Online 4, 56-61 https://doi.org/10.1016/S1472-6483(10)61916-5
- Han H, Irimia M, Ross PJ et al (2013) MBNL proteins repress ES-cell-specific alternative splicing and reprogramming. Nature 498, 241-245 https://doi.org/10.1038/nature12270
- Wang L, Ye X, Zhao Q et al (2014) Drp1 is dispensable for mitochondria biogenesis in induction to pluripotency but required for differentiation of embryonic stem cells. Stem Cells Dev 23, 2422-2434 https://doi.org/10.1089/scd.2014.0059
- Otera H and Mihara K (2011) Molecular mechanisms and physiologic functions of mitochondrial dynamics. J Biochem 149, 241-251 https://doi.org/10.1093/jb/mvr002
- Ramanathan A and Schreiber SL (2009) Direct control of mitochondrial function by mTOR. Proc Natl Acad Sci U S A 106, 22229-22232 https://doi.org/10.1073/pnas.0912074106
- Wang S, Xia P, Ye B, Huang G, Liu J and Fan Z (2013) Transient activation of autophagy via Sox2-mediated suppression of mTOR is an important early step in reprogramming to pluripotency. Cell Stem Cell 13, 617-625 https://doi.org/10.1016/j.stem.2013.10.005
- Greer EL, Dowlatshahi D, Banko MR et al (2007) An AMPK-FOXO pathway mediates longevity induced by a novel method of dietary restriction in C. elegans. Curr Biol 17, 1646-1656 https://doi.org/10.1016/j.cub.2007.08.047
- Wang Z, Zang C, Rosenfeld JA et al (2008) Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 40, 897-903 https://doi.org/10.1038/ng.154
- Lee S, Park JR, Seo MS et al (2009) Histone deacetylase inhibitors decrease proliferation potential and multilineage differentiation capability of human mesenchymal stem cells. Cell Prolif 42, 711-720 https://doi.org/10.1111/j.1365-2184.2009.00633.x
- Michishita E, McCord RA, Berber E et al (2008) SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature 452, 492-496 https://doi.org/10.1038/nature06736
- Chen T, Shen L, Yu J et al (2011) Rapamycin and other longevity-promoting compounds enhance the generation of mouse induced pluripotent stem cells. Aging Cell 10, 908-911 https://doi.org/10.1111/j.1474-9726.2011.00722.x
- Huangfu D, Maehr R, Guo W et al (2008) Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol 26, 795-797 https://doi.org/10.1038/nbt1418
- Vaquero A, Scher M, Lee D, Erdjument-Bromage H, Tempst P and Reinberg D (2004) Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol Cell 16, 93-105 https://doi.org/10.1016/j.molcel.2004.08.031
- Zhang ZN, Chung SK, Xu Z and Xu Y (2014) Oct4 maintains the pluripotency of human embryonic stem cells by inactivating p53 through Sirt1-mediated deacetylation. Stem Cells 32, 157-165 https://doi.org/10.1002/stem.1532
- Etchegaray JP, Chavez L, Huang Y et al (2015) The histone deacetylase SIRT6 controls embryonic stem cell fate via TET-mediated production of 5-hydroxymethylcytosine. Nat Cell Biol 17, 545-557 https://doi.org/10.1038/ncb3147
- Peng CH, Cherng JY, Chiou GY et al (2011) Delivery of Oct4 and SirT1 with cationic polyurethanes-short branch PEI to aged retinal pigment epithelium. Biomaterials 32, 9077-9088 https://doi.org/10.1016/j.biomaterials.2011.08.008
- Liu PY, Xu N, Malyukova A et al (2013) The histone deacetylase SIRT2 stabilizes Myc oncoproteins. Cell Death Differ 20, 503-514 https://doi.org/10.1038/cdd.2012.147
- Mao B, Zhao G, Lv X et al (2011) Sirt1 deacetylates c-Myc and promotes c-Myc/Max association. Int J Biochem Cell Biol 43, 1573-1581 https://doi.org/10.1016/j.biocel.2011.07.006
- Vaziri H, Dessain SK, Ng Eaton E et al (2001) hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107, 149-159 https://doi.org/10.1016/S0092-8674(01)00527-X
- Han MK, Song EK, Guo Y, Ou X, Mantel C and Broxmeyer HE (2008) SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization. Cell Stem Cell 2, 241-251 https://doi.org/10.1016/j.stem.2008.01.002
- Katada S, Imhof A and Sassone-Corsi P (2012) Connecting threads: epigenetics and metabolism. Cell 148, 24-28 https://doi.org/10.1016/j.cell.2012.01.001
- Ryall JG, Dell'Orso S, Derfoul A et al (2015) The NAD(+)-dependent SIRT1 deacetylase translates a metabolic switch into regulatory epigenetics in skeletal muscle stem cells. Cell Stem Cell 16, 171-183 https://doi.org/10.1016/j.stem.2014.12.004
- Zwaans BM and Lombard DB (2014) Interplay between sirtuins, MYC and hypoxia-inducible factor in cancerassociated metabolic reprogramming. Dis Model Mech 7, 1023-1032 https://doi.org/10.1242/dmm.016287
- Tennen RI, Bua DJ, Wright WE and Chua KF (2011) SIRT6 is required for maintenance of telomere position effect in human cells. Nat Commun 2, 433 https://doi.org/10.1038/ncomms1443
- Kugel S and Mostoslavsky R (2014) Chromatin and beyond: the multitasking roles for SIRT6. Trends Biochem Sci 39, 72-81 https://doi.org/10.1016/j.tibs.2013.12.002
- Michishita E, McCord RA, Boxer LD et al (2009) Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6. Cell Cycle 8, 2664-2666 https://doi.org/10.4161/cc.8.16.9367
- Toiber D, Erdel F, Bouazoune K et al (2013) SIRT6 recruits SNF2H to DNA break sites, preventing genomic instability through chromatin remodeling. Mol Cell 51, 454-468 https://doi.org/10.1016/j.molcel.2013.06.018
- Galleano I, Schiedel M, Jung M, Madsen AS and Olsen CA (2016) A Continuous, Fluorogenic Sirtuin 2 Deacylase Assay: Substrate Screening and Inhibitor Evaluation. J Med Chem 59, 1021-1031 https://doi.org/10.1021/acs.jmedchem.5b01532
- Baur JA (2010) Biochemical effects of SIRT1 activators. Biochim Biophys Acta 1804, 1626-1634 https://doi.org/10.1016/j.bbapap.2009.10.025
- Gu XS, Wang ZB, Ye Z et al (2014) Resveratrol, an activator of SIRT1, upregulates AMPK and improves cardiac function in heart failure. Genet Mol Res 13, 323-335 https://doi.org/10.4238/2014.January.17.17
- Chaudhary N and Pfluger PT (2009) Metabolic benefits from Sirt1 and Sirt1 activators. Curr Opin Clin Nutr Metab Care 12, 431-437 https://doi.org/10.1097/MCO.0b013e32832cdaae
- Bruckbauer A, Zemel MB, Thorpe T et al (2012) Synergistic effects of leucine and resveratrol on insulin sensitivity and fat metabolism in adipocytes and mice. Nutr Metab (Lond) 9, 77 https://doi.org/10.1186/1743-7075-9-77
- Chauhan D, Bandi M, Singh AV et al (2011) Preclinical evaluation of a novel SIRT1 modulator SRT1720 in multiple myeloma cells. Br J Haematol 155, 588-598 https://doi.org/10.1111/j.1365-2141.2011.08888.x
- Lahusen TJ and Deng CX (2015) SRT1720 induces lysosomal-dependent cell death of breast cancer cells. Mol Cancer Ther 14, 183-192
- Maya JD, Morello A, Repetto Y et al (2001) Trypanosoma cruzi: inhibition of parasite growth and respiration by oxazolo(thiazolo)pyridine derivatives and its relationship to redox potential and lipophilicity. Exp Parasitol 99, 1-6 https://doi.org/10.1006/expr.2001.4638
- Vu CB, Bemis JE, Disch JS et al (2009) Discovery of imidazo[1,2-b]thiazole derivatives as novel SIRT1 activators. J Med Chem 52, 1275-1283 https://doi.org/10.1021/jm8012954
- Bonkowski MS and Sinclair DA (2016) Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds. Nat Rev Mol Cell Biol 17, 679-690 https://doi.org/10.1038/nrm.2016.93
- Camins A, Sureda FX, Junyent F et al (2010) Sirtuin activators: designing molecules to extend life span. Biochim Biophys Acta 1799, 740-749 https://doi.org/10.1016/j.bbagrm.2010.06.005
- Botta G, De Santis LP and Saladino R (2012) Current advances in the synthesis and antitumoral activity of SIRT1-2 inhibitors by modulation of p53 and pro-apoptotic proteins. Curr Med Chem 19, 5871-5884 https://doi.org/10.2174/092986712804143303
- Villalba JM and Alcain FJ (2012) Sirtuin activators and inhibitors. Biofactors 38, 349-359 https://doi.org/10.1002/biof.1032
- Verdin E, Hirschey MD, Finley LW and Haigis MC (2010) Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling. Trends Biochem Sci 35, 669-675 https://doi.org/10.1016/j.tibs.2010.07.003
- Wang TT, Schoene NW, Kim EK and Kim YS (2013) Pleiotropic effects of the sirtuin inhibitor sirtinol involves concentration-dependent modulation of multiple nuclear receptor-mediated pathways in androgen-responsive prostate cancer cell LNCaP. Mol Carcinog 52, 676-685 https://doi.org/10.1002/mc.21906
- Peck B, Chen CY, Ho KK et al (2010) SIRT inhibitors induce cell death and p53 acetylation through targeting both SIRT1 and SIRT2. Mol Cancer Ther 9, 844-855 https://doi.org/10.1158/1535-7163.MCT-09-0971
- Naia L and Rego AC (2015) Sirtuins: double players in Huntington's disease. Biochim Biophys Acta 1852, 2183-2194 https://doi.org/10.1016/j.bbadis.2015.07.003
- Chen J, Zhou Y, Mueller-Steiner S et al (2005) SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J Biol Chem 280, 40364-40374 https://doi.org/10.1074/jbc.M509329200
- Risitano R, Curro M, Cirmi S et al (2014) Flavonoid fraction of Bergamot juice reduces LPS-induced inflammatory response through SIRT1-mediated NF-kappaB inhibition in THP-1 monocytes. PLoS One 9, e107431 https://doi.org/10.1371/journal.pone.0107431
- Polyakova O, Borman S, Grimley R, Vamathevan J, Hayes B and Solari R (2012) Identification of novel interacting partners of Sirtuin6. PLoS One 7, e51555 https://doi.org/10.1371/journal.pone.0051555
- Mopert K, Hajek P, Frank S, Chen C, Kaufmann J and Santel A (2009) Loss of Drp1 function alters OPA1 processing and changes mitochondrial membrane organization. Exp Cell Res 315, 2165-2180 https://doi.org/10.1016/j.yexcr.2009.04.016
- Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE and Chan DC (2003) Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol 160, 189-200 https://doi.org/10.1083/jcb.200211046
- Chen H, Chomyn A and Chan DC (2005) Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J Biol Chem 280, 26185-26192 https://doi.org/10.1074/jbc.M503062200
- Christiansen EG (1949) Orientation of the mitochondria during mitosis. Nature 163, 361
- Cho DH, Nakamura T and Lipton SA (2010) Mitochondrial dynamics in cell death and neurodegeneration. Cell Mol Life Sci 67, 3435-3447 https://doi.org/10.1007/s00018-010-0435-2
- Wilkerson DC and Sankar U (2011) Mitochondria: a sulfhydryl oxidase and fission GTPase connect mitochondrial dynamics with pluripotency in embryonic stem cells. Int J Biochem Cell Biol 43, 1252-1256 https://doi.org/10.1016/j.biocel.2011.05.005
- Cipolat S, Martins de Brito O, Dal Zilio B and Scorrano L (2004) OPA1 requires mitofusin 1 to promote mitochondrial fusion. Proc Natl Acad Sci U S A 101, 15927-15932 https://doi.org/10.1073/pnas.0407043101
- Son MJ, Kwon Y, Son MY et al (2015) Mitofusins deficiency elicits mitochondrial metabolic reprogramming to pluripotency. Cell Death Differ 22, 1957-1969 https://doi.org/10.1038/cdd.2015.43
- Tanno M, Sakamoto J, Miura T, Shimamoto K and Horio Y (2007) Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J Biol Chem 282, 6823-6832 https://doi.org/10.1074/jbc.M609554200
- Bell EL and Guarente L (2011) The SirT3 divining rod points to oxidative stress. Mol Cell 42, 561-568 https://doi.org/10.1016/j.molcel.2011.05.008
- Giralt A, Hondares E, Villena JA et al (2011) Peroxisome proliferator-activated receptor-gamma coactivator-1alpha controls transcription of the Sirt3 gene, an essential component of the thermogenic brown adipocyte phenotype. J Biol Chem 286, 16958-16966 https://doi.org/10.1074/jbc.M110.202390
- Olichon A, Baricault L, Gas N et al (2003) Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J Biol Chem 278, 7743-7746 https://doi.org/10.1074/jbc.C200677200
- Park SH, Ozden O, Jiang H et al (2011) Sirt3, mitochondrial ROS, ageing, and carcinogenesis. Int J Mol Sci 12, 6226-6239 https://doi.org/10.3390/ijms12096226
- Ou X, Lee MR, Huang X, Messina-Graham S and Broxmeyer HE (2014) SIRT1 positively regulates autophagy and mitochondria function in embryonic stem cells under oxidative stress. Stem Cells 32, 1183-1194 https://doi.org/10.1002/stem.1641
- Yoshii SR and Mizushima N (2015) Autophagy machinery in the context of mammalian mitophagy. Biochim Biophys Acta 1853, 2797-2801 https://doi.org/10.1016/j.bbamcr.2015.01.013
- Eiyama A and Okamoto K (2015) PINK1/Parkin-mediated mitophagy in mammalian cells. Curr Opin Cell Biol 33, 95-101 https://doi.org/10.1016/j.ceb.2015.01.002
- Koh H, Kim H, Kim MJ, Park J, Lee HJ and Chung J (2012) Silent information regulator 2 (Sir2) and Forkhead box O (FOXO) complement mitochondrial dysfunction and dopaminergic neuron loss in Drosophila PTEN-induced kinase 1 (PINK1) null mutant. J Biol Chem 287, 12750-12758 https://doi.org/10.1074/jbc.M111.337907
- Lim JH, Lee YM, Chun YS, Chen J, Kim JE and Park JW (2010) Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Mol Cell 38, 864-878 https://doi.org/10.1016/j.molcel.2010.05.023
- Qiu X, Brown K, Hirschey MD, Verdin E and Chen D (2010) Calorie restriction reduces oxidative stress by SIRT3-mediated SOD2 activation. Cell Metab 12, 662-667 https://doi.org/10.1016/j.cmet.2010.11.015
- Sundaresan NR, Gupta M, Kim G, Rajamohan SB, Isbatan A and Gupta MP (2009) Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J Clin Invest 119, 2758-2771
- Morigi M, Perico L, Rota C et al (2015) Sirtuin 3-dependent mitochondrial dynamic improvements protect against acute kidney injury. J Clin Invest 125, 715-726 https://doi.org/10.1172/JCI77632